AI Stock Picks — NASDAQ 100

Wednesday, November 4, 2026  ·  Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days

Today's Market Mood

Cautious  Normal choppiness · VIX 16.6

NASDAQ 100 is in the grip of a sharp, broad-based unwind in AI/semiconductor and high-beta growth names (NVDA, AMD, MRVL, MU, INTC, LRCX, AMAT, STX, SNDK, CRWV, NBIS, ALAB all down 20-50% over 5-30 days and far from 52-week highs), while capital rotates defensively into consumer staples, healthcare, and select mega-cap tech that are holding near their highs with positive, sustained momentum. Given the depth of the correction in the index's largest weightings, near-term upside is selective rather than broad.

Severe AI/semiconductor capex unwind driving steep drawdowns across chip and AI-infrastructure namesDefensive rotation into consumer staples and beverage names (WMT, COST, KDP, MDLZ, SBUX, MNST, CCEP) sitting near 52-week highsHealthcare/biotech and med-tech showing standout sustained strength (AMGN, GILD, REGN, VRTX, GEHC, IDXX, DXCM, ISRG)Mega-cap tech (MSFT, AAPL, AMZN) relatively resilient versus the broader growth selloff

Today's Actionable List

Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.

0 of 4
0%
81 · 179.9%
179.9% / 60%
0 of 20
RankStockActionSizeEntry → TargetNotes
#1 KDP SKIP — $36.96 → $38.84
stop $33.67
 Half-Kelly sizes this at 0% — the odds carry no edge worth capital.
#2 DXCM SKIP — $88.52 → $93.08
stop $79.85
 Half-Kelly sizes this at 0% — the odds carry no edge worth capital.
#3 REGN SKIP — $930.94 → $978.43
stop $858.33
 Half-Kelly sizes this at 0% — the odds carry no edge worth capital.
#4 AMZN SKIP — $267.81 → $281.50
stop $244.24
 Half-Kelly sizes this at 0% — the odds carry no edge worth capital.

Already open: HUM (to Nov 11), TJX (to Nov 11), BNZL.L (to Nov 12), UNH (to Nov 14), DGE.L (to Nov 14), BATS.L (to Nov 15), TSCO.L (to Nov 15), ORLY (to Nov 15), KO (to Nov 18), ULVR.L (to Nov 18), ABNB (to Nov 18), MNST (to Nov 18) … and 69 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.

Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.

Behind the scenes: how each AI analyst did
Aria
10 picks
Blaze
15 picks
Nova
4 picks
Orion
9 picks
Quinn
8 picks

4 Stock Picks

Diversification filter applied: 1 pick removed due to high same-sector price correlation with a higher-ranked pick (MDLZ), avoiding concentrated sector exposure.
#1 KDPKeurig Dr Pepper Inc.
5/5 Agents Agree  Risk 4/10  ⚠ Conflicting Signals
Moderate conviction · 58%

Keurig Dr Pepper makes coffee, soda, and other beverages sold in grocery stores and restaurants everywhere. The stock has climbed steadily, recently boosted by a strong earnings report, and is outperforming the broader tech-heavy market as investors seek safer, steady-growth companies. The main risk is that after such a sharp run-up, the stock could pause or give back some gains if the earnings excitement fades.

Stop-loss$33.67-8.9%
Today's price$36.96
Target$38.84+5.1%
Agents estimate: $38.86 (+0.1% vs target)
If you invested $1,000
▲$1,051 if the target hits (+5.1%)
▼$911 if the stop-loss is hit (-8.9%)
The AI puts the chance of the win case at 58%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • The +19.6% 30-day return is almost entirely a single-day gap (previous close $30.37 to $36.955, +21.68%), and price ($36.955) is already pressed against the upper Bollinger Band ($37.28) with only 0.96% headroom to its 52-week high — this looks like a one-time earnings re-rating that's already priced in, not room for a fresh 5%+ leg.
  • RSI at 66 is framed as 'sustainable' but combined with the stock sitting right at its upper Bollinger band and near its 52-week high, it reads more like exhaustion from the gap than a trend with runway left.
Show the detailed analysis

Calibrated probability: 58% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.

Trade math

0.6:1
64%
+0.3%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 70% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
75%
Very High
Blaze
63%
High
Nova
68%
High
Orion
66%
High
Quinn
60%
Medium

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha
#2 DXCMDexCom, Inc.
4/5 Agents Agree  Risk 4/10
Moderate conviction · 58%

DexCom makes continuous glucose monitors used by people with diabetes. The stock has shown a strong recent bounce with healthy momentum and technical confirmation, following a solid earnings beat, even though its gain over the full past month is more modest. The main risk is that medical-device stocks can be sensitive to regulatory or insurance-reimbursement news, and the recent bounce could stall.

Stop-loss$79.85-9.8%
Today's price$88.52
Target$93.08+5.2%
Agents estimate: $93.21 (+0.1% vs target)
If you invested $1,000
▲$1,052 if the target hits (+5.2%)
▼$902 if the stop-loss is hit (-9.8%)
The AI puts the chance of the win case at 58%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • The 30-day period return is only 1.86-1.92% despite the touted +6.8% 5-day momentum — nearly the entire move happened in the last week, meaning the prior three weeks were flat-to-down and the 'outperformance vs benchmark' is a recency artifact, not sustained strength.
  • Price ($88.52) is pinned against the upper Bollinger Band ($89.62), and the MACD line is still negative (-0.516) despite the signal crossover — the 'bullish crossover' is a line crossing from deeply negative territory, not confirmation of a strong uptrend.
Show the detailed analysis

Calibrated probability: 58% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.

Trade math

0.5:1
66%
+0.1%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 70% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
75%
Very High
Blaze
63%
High
Nova
65%
High
Orion
63%
High
Quinn
—
—
The potential reward doesn't compare as favorably to the downside risk once price volatility is factored in, versus other candidates.

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha
#3 REGNRegeneron Pharmaceuticals, Inc.
4/5 Agents Agree  Risk 4/10  ⚠ Conflicting Signals
Moderate conviction · 58%

Regeneron is a biotechnology company known for treatments like Eylea for eye disease. The stock has surged over the past month on a big earnings beat and is sharply outperforming the broader tech market. The main risks are that the stock has already run up a lot, leaving less room before a pullback, and biotech stocks can move suddenly on clinical trial or regulatory news.

Stop-loss$858.33-7.8%
Today's price$930.94
Target$978.43+5.1%
Agents estimate: $979.37 (+0.1% vs target)
If you invested $1,000
▲$1,051 if the target hits (+5.1%)
▼$922 if the stop-loss is hit (-7.8%)
The AI puts the chance of the win case at 58%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • RSI at 69.56 is effectively at the 70 overbought threshold, not meaningfully below it as the thesis implies — this is a technicality, not real cushion.
  • The 28% 30-day return is driven by a single-day 26.62% gap (previous close $735.20 to $930.94); with price now just 2.8% below the upper Bollinger Band ($957.45), the earnings surprise looks already fully priced in, leaving little room for an additional 5% move without a pullback first.
Show the detailed analysis

Calibrated probability: 58% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.

Trade math

0.7:1
60%
+0.7%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 70% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
75%
Very High
Blaze
66%
High
Nova
—
—
No recent earnings or news catalyst was found — next earnings are nearly 3 months away, so the recent price gains lack a specific confirming event.
Orion
63%
High
Quinn
60%
Medium

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha
#4 AMZNAmazon.com, Inc.
3/5 Agents Agree  Risk 4/10
Moderate conviction · 58%

Amazon runs the world's largest online store and its cloud-computing arm, AWS, which is now growing at its fastest pace in five years. The company posted its highest-ever operating margin and AWS revenue accelerated to 39% growth, even though per-share profit technically missed estimates due to a one-time accounting item from last year. The stock is still nearly 7% below its 52-week high, and the main risk is that overall market jitters around AI spending could weigh on sentiment toward its cloud business.

Stop-loss$244.24-8.8%
Today's price$267.81
Target$281.50+5.1%
Agents estimate: $281.80 (+0.1% vs target)
If you invested $1,000
▲$1,051 if the target hits (+5.1%)
▼$912 if the stop-loss is hit (-8.8%)
The AI puts the chance of the win case at 58%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • Recent 5-day momentum is actually negative (-0.62%), directly contradicting the 'strong recent momentum' framing — the 30-day gain is backloaded into one earlier spike, not an accelerating move.
  • Price ($267.81) is sitting right at the upper Bollinger Band ($268.09) and the MACD line remains negative (-0.537) despite the crossover — a weak signal from below zero, not strong confirmed trend strength. This pick also has the lowest agent consensus of the four (3/5).
Show the detailed analysis

Calibrated probability: 58% (raw model estimate: 60%) — adjusted using the accuracy of past resolved picks.

Trade math

0.6:1
63%
-0.5%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 70% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
—
—
5-day momentum is negative (-0.62%), failing the short-term momentum requirement.
Blaze
63%
High
Nova
—
—
Its last earnings report was a miss (about 3.5% below estimates), not a beat, so it doesn't qualify as a positive catalyst.
Orion
58%
Medium
Quinn
60%
Medium

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha

Retail Investor Execution Guide

This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by December 4, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.

Step-by-Step Action Plan

  1. Act within one trading day. Prices are freshest now. The longer you wait, the more the entry price drifts away from what the agents analysed.
  2. Verify the entry price. Check the live price before buying. If a stock has already moved more than 3% above the Current Price shown in the report, skip it or wait for a pullback — the risk/reward has shifted.
  3. Use limit orders, not market orders. Set your buy limit at or below the Current Price shown. Chasing with a market order gives brokers and algorithms an advantage over you.
  4. Set your stop-loss immediately after buying. Use the Max Downside % on each pick card as your hard exit level. If the price falls to that level, sell without hesitation — the trade thesis is broken.
  5. Set a take-profit at the Target Price. Place a limit sell order at the Target Price shown. When it fills, the trade is done — resist the urge to hold for more.
  6. Exit all positions by December 4, 2026. This is your hard deadline. If a stock has not hit its target by then, exit anyway. Holding past the window turns a short-term trade into an unsupervised long-term position.
  7. Never add to a losing position. If your stop-loss is hit, exit completely. Averaging down turns a small, controlled loss into a potentially large one.

Position Sizing by Conviction Tier

Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.

Agents Agreeing What It Means Max Allocation Per Pick
5/5 Highest conviction — all five independent analytical checks passed Up to 10%
4/5 Very high conviction — four of five independent checks aligned Up to 8%
3/5 High conviction — three agents independently agreed Up to 6%
2/5 Moderate conviction — two agents independently agreed Up to 4%
1 Agent Speculative — solo pick, admitted only at Very High confidence Up to 2%

The Three Exit Rules

These picks are generated by AI agents for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Probability estimates reflect the agents' analytical models — they are not guarantees of any outcome. Past results are not indicative of future performance. Markets can and do move against even well-researched trades. Always conduct your own research, and consider seeking advice from a licensed financial adviser before placing any orders. Never invest money you cannot afford to lose.

Understanding the Numbers

A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.

AI Conviction Meter
Estimated probability of hitting the target, shown as a 5-bar gauge
The filled bars and label translate the AI's probability estimate into plain language: 75%+ is Very strong, 60–74% Strong, 50–59% Moderate, below 50% Cautious. Where enough past picks have been resolved, the probability is calibrated against the AI's real track record.
e.g. "Moderate conviction · 58%" — the AI thinks this trade works slightly more often than a coin flip.
✓ More filled bars = more confidence — but even Very strong picks fail sometimes; always size positions accordingly.
If You Invested $1,000
$1,000 × (1 + Target Gain ÷ 100)  /  $1,000 × (1 + Max Downside ÷ 100)
The same Target Gain and Max Downside percentages expressed in concrete money terms for a $1,000 position — what you'd have if the target hits versus if your stop-loss is triggered.
e.g. +10% target and −12.3% stop → $1,100 on a win, $877 on a stopped-out loss.
✓ Scales linearly — a $500 position sees half these amounts, a $2,000 position double.
Current Price
Market price at time of analysis
The stock's price when this report was generated. All other figures on the card are calculated from this reference point.
e.g. $215.20 — check the live price before placing an order; if it has moved more than ~3%, re-evaluate the risk/reward.
✓ No positive/negative distinction — it is simply your cost basis.
Target Price
Current Price × (1 + Target Gain ÷ 100)
The price the agents project the stock could reach within the time window. This is your take-profit level — place a limit sell order here after buying.
e.g. $215.20 × 1.085 = $233.49 target on an 8.5% pick.
✓ Always above Current Price — this tool only selects upside candidates.
Target Gain
(Target Price − Current Price) ÷ Current Price × 100
The percentage return you would earn if the stock hits its Target Price from your entry. Set by the run parameters — every pick in this report targets the same percentage.
e.g. +8.5% means a $100 stock has a $108.50 target; a $500 stock has a $542.50 target.
✓ Always positive — picks are upside-only. A larger % means a bigger move is required.
Max Downside
Estimated stop-loss level, as % below entry
The worst-case loss the agents estimated if the thesis fails — based on key support levels and recent volatility. Use this as your hard stop-loss. If the price falls to this level, exit immediately; the trade thesis is broken.
e.g. −12.0% means: if you bought at $100, sell if it drops to $88.00.
⚠ Always negative. A smaller magnitude (e.g. −5%) = tighter risk. A larger magnitude (e.g. −20%) = more room to fall before you exit — riskier.
Reward : Risk
Target Gain ÷ |Max Downside|
How much you could gain for every dollar you are risking. A ratio of 2.0:1 means you stand to make $2 for every $1 at risk. Higher is better.
e.g. 8.5% gain ÷ 12% downside = 0.7:1 (unfavourable). 10% gain ÷ 5% downside = 2.0:1 (good).
✓ ≥ 2.0:1 is strong. ⚠ < 1.0:1 means you are risking more than you could gain — approach with caution.
Breakeven Win Rate
|Max Downside| ÷ (Target Gain + |Max Downside|) × 100
The minimum percentage of trades at this reward:risk that must succeed for you to break even over time — regardless of how good your stock picking is.
e.g. 12 ÷ (8.5 + 12) = 59% — you need roughly 6 in 10 trades to win just to avoid losing money.
✓ Lower is better — ≤ 35% means even a poor win rate is survivable. ⚠ ≥ 55% means you need most trades to work out.
Expected Value
(Probability% × Target Gain%) + ((1 − Probability%) × Max Downside%)
The average return per trade if the AI's probability estimate is accurate over many similar trades. A positive Expected Value means the trade has a mathematical edge; a negative value means the math works against you on average, even if you sometimes win.
e.g. 65% × +8.5% + 35% × −12% = +1.3% EV. Over 100 similar trades you would expect an average gain of 1.3% per trade.
✓ Positive = edge in your favour over many trades. ⚠ Negative = the math loses money on average — even if individual wins feel good. Note: EV is only as reliable as the probability estimate.
Suggested Allocation
half-Kelly: (Probability ÷ |Max Downside| − (1 − Probability) ÷ Target Gain) ÷ 2, capped at 10%
The Kelly criterion computes the portfolio fraction that maximises long-run growth for a bet with these odds; half-Kelly is the standard hedge against the probability estimate being too optimistic. Uses the calibrated probability where available. 0% means the math sees no edge worth sizing; — means it couldn't be computed.
e.g. 57% probability, +10% target, −13% downside → Kelly ≈ 8.5% of portfolio, half-Kelly ≈ 4.2%.
Generic sizing guidance only — not personal investment advice. Position sizing must reflect your own portfolio, risk tolerance and circumstances.
Every stock Scout considered — and why each was discarded

Scout scanned 101 NASDAQ 100 constituents and short-listed 25 candidates for deep analysis by the five analysts. Here is what happened to each one.

  • ROPRoper Technologies, Inc.Dropped at merge
    Scout: Trading essentially at its 52-week high with +12% 5-day and +36% 30-day returns, among the strongest and most sustained momentum in the index.
    Qualified on merit but ranked #14, outside the 5-pick limit for this run.
  • CTASCintas CorporationAlready held
    Scout: Within 0.3% of its 52-week high with +8% 5-day and +18% 30-day gains, showing steady uninterrupted strength.
    Already held: a position opened 2026-10-21 runs until 2026-11-20 (16 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • AMGNAmgen Inc.Already held
    Scout: Near its 52-week high (-0.9%) with consistent 5-day and 30-day gains, benefiting from the rotation into healthcare.
    Already held: a position opened 2026-10-29 runs until 2026-11-28 (24 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • KDPKeurig Dr Pepper Inc.Picked #1
    Scout: Sitting just under its 52-week high with strong 5-day and 30-day momentum as staples attract defensive flows.
    Made the final report at #1.
  • MDLZMondelez International, Inc.Diversification filter
    Scout: Near 52-week high with sustained momentum across both windows, part of the broad staples bid.
    Dropped by diversification filter: 0.73 30-day daily-return correlation with KDP (both in Consumer Defensive).
  • GILDGilead Sciences, Inc.Already held
    Scout: Within 0.6% of its 52-week high with strong 5-day and 30-day returns, a leading beneficiary of the healthcare rotation.
    Already held: a position opened 2026-10-30 runs until 2026-11-29 (25 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • MSFTMicrosoft CorporationDropped at merge
    Scout: Trading near its 52-week high with positive 5-day and 30-day returns, one of the few mega-cap tech names resisting the broader selloff.
    Qualified on merit but ranked #11, outside the 5-pick limit for this run.
  • AAPLApple Inc.Dropped at merge
    Scout: Essentially at its 52-week high with consistent short- and medium-term gains, showing relative stability versus peers.
    Qualified on merit but ranked #12, outside the 5-pick limit for this run.
  • CCEPCoca-Cola Europacific Partners PLCDropped at merge
    Scout: Near its 52-week high with steady 5-day and 30-day gains as beverage/staples names outperform.
    Qualified on merit but ranked #9, outside the 5-pick limit for this run.
  • SBUXStarbucks CorporationDropped at merge
    Scout: Within 1% of its 52-week high with solid sustained momentum across both windows.
    Qualified on merit but ranked #7, outside the 5-pick limit for this run.
  • ADPAutomatic Data Processing, Inc.Dropped at merge
    Scout: Close to its 52-week high with steady positive momentum, a defensive services name holding up well.
    Qualified on merit but ranked #10, outside the 5-pick limit for this run.
  • MNSTMonster Beverage CorporationAlready held
    Scout: Near its 52-week high with consistent gains over both the 5-day and 30-day windows.
    Already held: a position opened 2026-10-19 runs until 2026-11-18 (14 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • CSXCSX CorporationAlready held
    Scout: Within 3% of its 52-week high with a steady positive 30-day trend and no signs of the broader selloff.
    Already held: a position opened 2026-10-22 runs until 2026-11-21 (17 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • ROSTRoss Stores, Inc.Already held
    Scout: Near its 52-week high with balanced, sustained 5-day and 30-day gains.
    Already held: a position opened 2026-10-20 runs until 2026-11-19 (15 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • WMTWalmart Inc.Already held
    Scout: Trading close to its 52-week high with strong, consistent momentum, a key beneficiary of defensive positioning.
    Already held: a position opened 2026-11-02 runs until 2026-12-02 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • XELXcel Energy Inc.Already held
    Scout: Near its 52-week high with steady gains, benefiting from rotation into defensive utilities.
    Already held: a position opened 2026-11-03 runs until 2026-12-03 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • COSTCostco Wholesale CorporationAlready held
    Scout: Within 4% of its 52-week high with sustained momentum, a steady defensive retail name.
    Already held: a position opened 2026-11-03 runs until 2026-12-03 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • VRTXVertex Pharmaceuticals IncorporatedDropped at merge
    Scout: Near its 52-week high with positive momentum across both windows, part of the healthcare strength theme.
    Qualified on merit but ranked #8, outside the 5-pick limit for this run.
  • LINLinde plcDropped at merge
    Scout: Close to its 52-week high with consistent 5-day and 30-day gains, a stable industrial-gas name.
    Qualified on merit but ranked #13, outside the 5-pick limit for this run.
  • GEHCGE HealthCare Technologies Inc.Dropped at merge
    Scout: Strong +13.5% 5-day and +31% 30-day returns while staying within 4% of its 52-week high.
    Reward-to-risk 0.44 is below the 0.50 minimum — a +5.47% target against a -12.5% stop.
  • REGNRegeneron Pharmaceuticals, Inc.Picked #3
    Scout: Outsized +14% 5-day and +28% 30-day momentum while only 6% off its 52-week high.
    Made the final report at #3.
  • AMZNAmazon.com, Inc.Picked #4
    Scout: Positive 5-day and 30-day returns with a relatively modest 7% pullback from its high, holding up better than most mega-cap tech peers.
    Made the final report at #4.
  • PAYXPaychex, Inc.Dropped at merge
    Scout: Strong +10% 5-day and +19% 30-day gains while only 7% off its 52-week high.
    Qualified on merit but ranked #6, outside the 5-pick limit for this run.
  • IDXXIDEXX Laboratories, Inc.Dropped at merge
    Scout: Standout +24% 5-day and +33% 30-day momentum, among the strongest in the index despite being 9% off its high.
    Only Blaze selected this stock — single-agent picks require Very High confidence and at least 70% probability (this pick: Very High, 83% raw (67% after calibration)).
  • DXCMDexCom, Inc.Picked #2
    Scout: Sharp +12.6% 5-day acceleration with only a 4.4% gap to its 52-week high, suggesting renewed near-term buying interest.
    Made the final report at #2.

Agent Analytical Approaches

Aria

Momentum & Technical

Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.

Blaze

Fundamental & Earnings

Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).

Nova

News Catalyst & Event-Driven

Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.

Orion

Macro & Sector Rotation

Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.

Sage

Devil's Advocate

Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.

Quinn

Quantitative / Statistical

Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.